IBM's (IBM) Software business underperformed in Q1, so the company's execution for the rest of the year needs to be "flawless" to maintain the stock's premium valuation, Morgan Stanley said in a Thursday note.
Meanwhile, stronger free cash flow generation, although a bit dependent on a weak US dollar, could offset the underperformance, Morgan Stanley analysts said. At the current spot rates, they said they expect free cash flow to outperform the company's guidance.
The company said it observed no change in buying behavior in Q1 and the first three weeks of Q2, but if the macro environment worsens, there may be "greater variability" in the Consulting business, consumption-based services in RedHat and parts of its Distributed Infrastructure business, the analysts noted.
Morgan Stanley maintained the stock's rating at equal-weight and revised the price target to $233 from $237.
Price: 230.92, Change: -14.56, Percent Change: -5.93
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.